Molbio Diagnostics and UE LifeSciences announce an exclusive collaboration to expand iBreastExam, a radiation-free, painless, and FDA-cleared breast health screening device, across India, Africa, the Middle East, and beyond. The partnership aims to bring accessible early detection to millions of women in over 50 countries.
Goa-based Molbio Diagnostics, backed by Temasek and MOPE, has filed its DRHP with SEBI for an IPO comprising a fresh issue of ₹200 crore and an OFS of 1.25 crore equity shares. The funds will be utilized for R&D infrastructure, manufacturing expansion, and corporate purposes.
With over 190,000 undiagnosed TB cases annually, the Philippines is turning to Indian innovation to close the gap. Through Molbio Diagnostics' WHO-endorsed Truenat® systems and portable X-ray solutions, the country is enhancing its ability to screen, diagnose, and treat TB—especially in remote and underserved communities.
Molbio Diagnostics has expanded its CSR footprint by inaugurating Occupational Therapy and Audiology Units at Aastha’s Centre of Excellence in Goa. These facilities aim to benefit over 100 children with disabilities annually by offering sensory and communication therapies, bridging key healthcare access gaps in the state.
Molbio Diagnostics, in partnership with the Goa CSR Authority, donated 10 electric garbage collection vehicles to the Sankhalim Municipal Council on June 5, 2025. This green initiative supports clean, cost-efficient waste management and advances Goa’s vision for sustainable urban living.
